Rationalization of Mushroom-Based Preventive and Therapeutic Approaches to COVID-19: Review
| Autor: | Shajib Kumar Saha, Rajib Mia, Abul Hossain, Akther Jahan Kakon, Mohammad Saidur Rahman, Nirod Chandra Sarker, Mohammad Azizur Rahman, Nurul Mostafa Bin Bashir |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Reishi Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Angiotensin-Converting Enzyme Inhibitors Rationalization (economics) Antiviral Agents Applied Microbiology and Biotechnology Original research Mice Global population Drug Discovery medicine Animals Humans Immunologic Factors Intensive care medicine Ganoderma lucidum Pharmacology Biological Products Mushroom SARS-CoV-2 business.industry fungi COVID-19 medicine.disease Agaricales Cytokine Release Syndrome business Pneumonia (non-human) |
| Zdroj: | International Journal of Medicinal Mushrooms. 23:1-11 |
| ISSN: | 1521-9437 |
| Popis: | Since December 2019, a de novo pattern of pneumonia, later named coronavirus disease 2019 (COVID-19), has caused grave upset throughout the global population. COVID-19 is associated with several comorbidities; thus, preventive and therapeutic strategies targeting those comorbidities along with the causative agent, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), seem imperative. In this state-of-the-art review, edible and medicinal mushrooms are featured in the treatment of SARS-CoV-2, COVID-19 pathomanifestations, and comorbid issues. Because this is not an original research article, we admit our shortcomings in inferences. Yet we are hopeful that mushroom-based therapeutic approaches can be used to achieve a COVID-free world. Among various mushroom species, reishi or lingzhi (Ganoderma lucidum) seem most suitable as anti-COVID agents for the global population. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|